Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$711,369
+$53,826 QoQ
Shares Held
2,801
+4.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#3,341
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intellectus Partners, LLC holds $12,763,770 across 10 Drug Manufacturers - General names. JNJ ranks #8 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
11,595 | $2,917,765 | |
| 2 | LLY |
ELI LILLY & Co
|
1,918 | $2,300,506 | |
| 3 | NVO |
Novo Nordisk A S
|
33,631 | $1,612,270 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,435 | $1,212,397 | |
| 5 | PFE |
Pfizer Inc
|
48,637 | $1,171,178 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,947 | $1,130,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,002 | $979,655 | |
| 8 | JNJ |
Johnson & Johnson
This page
|
2,801 | $711,369 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $711,369 | 2,801 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $657,543 | 2,690 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $2,035,353 | 9,835 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,865,510 | 10,061 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,518,029 | 9,938 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,635,679 | 9,863 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,412,937 | 9,770 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,509,588 | 9,315 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,294,100 | 8,854 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,259,034 | 7,959 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,110,032 | 7,082 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $869,240 | 5,581 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $862,193 | 5,209 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $798,715 | 5,153 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $907,981 | 5,140 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $972,808 | 5,955 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,830,305 | 10,311 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,966,366 | 11,095 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,949,855 | 11,398 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,785,382 | 11,055 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,177,232 | 7,146 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,172,965 | 7,137 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,160,362 | 7,373 | Shares | Sole | 2021-02-18 | |
| 2020-09-30 | $1,153,224 | 7,746 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,110,555 | 7,897 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,214,001 | 9,258 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||